[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Magnetoencephalography Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By End Use (Imaging Centers, Academic & Research Institutes), By Region, And Segment Forecasts, 2024 - 2030

July 2024 | 180 pages | ID: MAA2AA49125FEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Magnetoencephalography Market Growth & Trends

The global magnetoencephalography market size is expected t%li%reach USD 432.56 million by 2030, expanding at a CAGR of 5.9% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The growing frequency of new product launches and the rise in the incidence of neurological disorders such as epilepsy, and stroke are key drivers t%li%market growth. In addition, the growing geriatric population is als%li%expected t%li%drive market growth since they are more prone t%li%neurodegenerative diseases. According t%li%the World Health Organization, neurological disorders are a leading cause of death, accounting for 12% of all deaths worldwide.

MEG technologies detect the weak magnetic fields created in the brain and use them t%li%quantify brain functionality and map brain activity. In a clinical setting, MEG provides a number of inherent applications. Scans can be performed in a safe and silent atmosphere due t%li%the passive nature of the recordings, which even allows a patient's companion t%li%be present within the shielded area.

Technological developments are likely t%li%contribute t%li%market expansion, such as the introduction of whole-head systems and developments in computer technology, MEG has evolved significantly in the last tw%li%decades. Whenever a precise and high degree of localization is required, MEG is now the imaging modality of choice. Furthermore, magnetoencephalography (MEG), is an invaluable tool that is used by researchers t%li%study the connections and dynamics of large-scale brain activity.

The market's prominent competitors are acquiring medium and small-sized businesses in order t%li%expand their product portfoli%li%and enhance their manufacturing capacity. For instance, the University of Nottingham has partnered with Magnetic Shields Limited (MSL) of Kent t%li%develop Cerca Magnetics Limited, a new spin-out company that will deliver the world's most advanced functional wearable brain scanner t%li%market. It is designed t%li%let people move around freely while being scanned.

Magnetoencephalography Market Report Highlights
    • By application, the clinical segment dominated the market in 2023 and is further expected t%li%grow at the fastest CAGR of about 6.0% over the forecast period.
      • The clinical segment is further sub-segmented int%li%dementia, autism, schizophrenia, multiple sclerosis, stroke, epilepsy, and others, in which the epilepsy sub-segment held the largest market share owing t%li%its increasing prevalence worldwide
    • In terms of end use, the hospital segment held the largest share in 2023, owing t%li%the increasing number of hospitals in developing countries and growing competition among healthcare service providers
        • The imaging center segment is expected t%li%experience the fastest growth rate during the forecast period due t%li%its convenience, proximity, and lower costs t%li%patients and insurers
      • Asia Pacific is anticipated t%li%be growing at the fastest CAGR during the forecast period due t%li%the presence of untapped opportunities in the emerging economies in China and India
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Segment Definitions
  1.2.1. Application
  1.2.2. End Use
  1.2.3. Regional scope
  1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
  1.4.1. Purchased database
  1.4.2. GVR’s internal database
  1.4.3. Secondary sources
  1.4.4. Primary research
  1.4.5. Details of primary research
    1.4.5.1. Data for primary interviews in North America
    1.4.5.2. Data for primary interviews in Europe
    1.4.5.3. Data for primary interviews in Asia Pacific
    1.4.5.4. Data for primary interviews in Latin America
    1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
  1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
  1.7.1. Commodity flow analysis (Model 1)
  1.7.2. Approach 1: Commodity flow approach
  1.7.3. Volume price analysis (Model 2)
  1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
  2.2.1. Application Outlook
  2.2.2. End Use Outlook
  2.2.3. Regional Outlook
2.3. Competitive Insights

CHAPTER 3. MAGNETOENCEPHALOGRAPHY MARKET VARIABLES, TRENDS & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent market outlook
  3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
    3.2.1.1. Increase in prevalence of neurological disorders
    3.2.1.2. Technological advancements
  3.2.2. Market Restraint Analysis
    3.2.2.1. High cost of MEG
    3.2.2.2. Presence of alternative diagnostic devices
3.3. Magnetoencephalography Market Analysis Tools
  3.3.1. Industry Analysis - Porter’s
    3.3.1.1. Supplier power
    3.3.1.2. Buyer power
    3.3.1.3. Substitution threat
    3.3.1.4. Threat of new entrant
    3.3.1.5. Competitive rivalry
  3.3.2. PESTEL Analysis
    3.3.2.1. Political landscape
    3.3.2.2. Technological landscape
    3.3.2.3. Economic landscape

CHAPTER 4. MAGNETOENCEPHALOGRAPHY MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. Global Magnetoencephalography Application Market Movement Analysis
4.3. Global Magnetoencephalography Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
4.4. Clinical
  4.4.1. Clinical market estimates and forecasts 2018 - 2030 (USD Million)
  4.4.2. Dementia
    4.4.2.1. Dementia market estimates and forecasts 2018 - 20302030 (USD Million)
  4.4.3. Autism
    4.4.3.1. Autism market estimates and forecasts 2018 - 2030 (USD Million)
  4.4.4. Schizophrenia
    4.4.4.1. Schizophrenia market estimates and forecasts 2018 - 2030 (USD Million)
  4.4.5. Multiple Sclerosis
    4.4.5.1. Multiple sclerosis market estimates and forecasts 2018 - 2030 (USD Million)
  4.4.6. Stroke
    4.4.6.1. Stroke market estimates and forecasts 2018 - 2030 (USD Million)
  4.4.7. Epilepsy
    4.4.7.1. Epilepsy market estimates and forecasts 2018 - 2030 (USD Million)
  4.4.8. Others
    4.4.8.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Research
  4.5.1. Research market estimates and forecasts 2018 - 2030 (USD Million)

CHAPTER 5. MAGNETOENCEPHALOGRAPHY MARKET: END USE ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. Global Magnetoencephalography End Use Market Movement Analysis
5.3. Global Magnetoencephalography Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
5.4. Hospitals
  5.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Imaging Centers
  5.5.1. Imaging centers market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Academic and Research Institutes
  5.6.1. Academic and research institutes market estimates and forecasts 2018 - 2030 (USD Million)

CHAPTER 6. MAGNETOENCEPHALOGRAPHY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY APPLICATION, END USE

6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
  6.5.1. U.S.
    6.5.1.1. Key country dynamics
    6.5.1.2. Competitive scenario
    6.5.1.3. Regulatory framework/ reimbursement structure
    6.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  6.5.2. Canada
    6.5.2.1. Key country dynamics
    6.5.2.2. Competitive scenario
    6.5.2.3. Regulatory framework/ reimbursement structure
    6.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Europe
  6.6.1. Regulatory framework/ reimbursement structure
  6.6.2. UK
    6.6.2.1. Key country dynamics
    6.6.2.2. Competitive scenario
    6.6.2.3. Regulatory framework/ reimbursement structure
    6.6.2.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.3. Germany
    6.6.3.1. Key country dynamics
    6.6.3.2. Competitive scenario
    6.6.3.3. Regulatory framework/ reimbursement structure
    6.6.3.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.4. France
    6.6.4.1. Key country dynamics
    6.6.4.2. Competitive scenario
    6.6.4.3. Regulatory framework/ reimbursement structure
    6.6.4.4. France market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.5. Italy
    6.6.5.1. Key country dynamics
    6.6.5.2. Competitive scenario
    6.6.5.3. Regulatory framework/ reimbursement structure
    6.6.5.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.6. Spain
    6.6.6.1. Key country dynamics
    6.6.6.2. Competitive scenario
    6.6.6.3. Regulatory framework/ reimbursement structure
    6.6.6.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.7. Norway
    6.6.7.1. Key country dynamics
    6.6.7.2. Competitive scenario
    6.6.7.3. Regulatory framework/ reimbursement structure
    6.6.7.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.8. Sweden
    6.6.8.1. Key country dynamics
    6.6.8.2. Competitive scenario
    6.6.8.3. Regulatory framework/ reimbursement structure
    6.6.8.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  6.6.9. Denmark
    6.6.9.1. Key country dynamics
    6.6.9.2. Competitive scenario
    6.6.9.3. Regulatory framework/ reimbursement structure
    6.6.9.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Asia Pacific
  6.7.1. Regulatory framework/ reimbursement structure
  6.7.2. Japan
    6.7.2.1. Key country dynamics
    6.7.2.2. Competitive scenario
    6.7.2.3. Regulatory framework/ reimbursement structure
    6.7.2.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  6.7.3. China
    6.7.3.1. Key country dynamics
    6.7.3.2. Competitive scenario
    6.7.3.3. Regulatory framework/ reimbursement structure
    6.7.3.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  6.7.4. India
    6.7.4.1. Key country dynamics
    6.7.4.2. Competitive scenario
    6.7.4.3. Regulatory framework/ reimbursement structure
    6.7.4.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  6.7.5. Australia
    6.7.5.1. Key country dynamics
    6.7.5.2. Competitive scenario
    6.7.5.3. Regulatory framework/ reimbursement structure
    6.7.5.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  6.7.6. South Korea
    6.7.6.1. Key country dynamics
    6.7.6.2. Competitive scenario
    6.7.6.3. Regulatory framework/ reimbursement structure
    6.7.6.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  6.7.7. Thailand
    6.7.7.1. Key country dynamics
    6.7.7.2. Competitive scenario
    6.7.7.3. Regulatory framework/ reimbursement structure
    6.7.7.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Latin America
  6.8.1. Regulatory framework/ reimbursement structure
  6.8.2. Brazil
    6.8.2.1. Key country dynamics
    6.8.2.2. Competitive scenario
    6.8.2.3. Regulatory framework/ reimbursement structure
    6.8.2.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  6.8.3. Mexico
    6.8.3.1. Key country dynamics
    6.8.3.2. Competitive scenario
    6.8.3.3. Regulatory framework/ reimbursement structure
    6.8.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  6.8.4. Argentina
    6.8.4.1. Key country dynamics
    6.8.4.2. Competitive scenario
    6.8.4.3. Regulatory framework/ reimbursement structure
    6.8.4.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.9. MEA
  6.9.1. Regulatory framework/ reimbursement structure
  6.9.2. South Africa
    6.9.2.1. Key country dynamics
    6.9.2.2. Competitive scenario
    6.9.2.3. Regulatory framework/ reimbursement structure
    6.9.2.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  6.9.3. Saudi Arabia
    6.9.3.1. Key country dynamics
    6.9.3.2. Competitive scenario
    6.9.3.3. Regulatory framework/ reimbursement structure
    6.9.3.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  6.9.4. UAE
    6.9.4.1. Key country dynamics
    6.9.4.2. Competitive scenario
    6.9.4.3. Regulatory framework/ reimbursement structure
    6.9.4.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  6.9.5. Kuwait
    6.9.5.1. Key country dynamics
    6.9.5.2. Competitive scenario
    6.9.5.3. Regulatory framework/ reimbursement structure
    6.9.5.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2023
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
  7.6.1. Compumedics Limited
    7.6.1.1. Company overview
    7.6.1.2. Financial performance
    7.6.1.3. Product benchmarking
    7.6.1.4. Strategic initiatives
  7.6.2. MEGIN
    7.6.2.1. Company overview
    7.6.2.2. Financial performance
    7.6.2.3. Product benchmarking
    7.6.2.4. Strategic initiatives
  7.6.3. Ricoh
    7.6.3.1. Company overview
    7.6.3.2. Financial performance
    7.6.3.3. Product benchmarking
    7.6.3.4. Strategic initiatives
  7.6.4. CTF MEG NEURO INNOVATIONS, INC.
    7.6.4.1. Company overview
    7.6.4.2. Financial performance
    7.6.4.3. Product benchmarking
    7.6.4.4. Strategic initiatives
  7.6.5. FieldLine Inc.
    7.6.5.1. Company overview
    7.6.5.2. Financial performance
    7.6.5.3. Product benchmarking
    7.6.5.4. Strategic initiatives
  7.6.6. Cerca Magnetics Limited
    7.6.6.1. Company overview
    7.6.6.2. Financial performance
    7.6.6.3. Product benchmarking
    7.6.6.4. Strategic initiatives
LIST OF TABLES


Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 4 Global magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 5 North America magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 6 North America magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 7 North America magnetoencephalography market by Country, 2018 - 2030 (USD Million)
Table 8 U.S. magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 9 U.S. magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 10 Canada magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 11 Canada magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 12 Europe magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 13 Europe magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 14 Europe magnetoencephalography market by Country, 2018 - 2030 (USD Million)
Table 15 UK magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 16 UK magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 17 Germany magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 18 Germany magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 19 France magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 20 France magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 21 Italy magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 22 Italy magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 23 Spain magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 24 Spain magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 25 Denmark magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 26 Denmark magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 27 Sweden magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 28 Sweden magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 29 Norway magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 30 Norway magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 31 Asia Pacific magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 32 Asia Pacific magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 33 Asia Pacific magnetoencephalography market by Country, 2018 - 2030 (USD Million)
Table 34 China magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 35 China magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 36 Japan magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 37 Japan magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 38 India magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 39 India magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 40 Australia magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 41 Australia magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 42 Thailand magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 43 Thailand magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 44 South Korea magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 45 South Korea magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 46 Latin America magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 47 Latin America magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 48 Latin America magnetoencephalography market by Country, 2018 - 2030 (USD Million)
Table 49 Brazil magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 50 Brazil magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 51 Mexico magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 52 Mexico magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 53 Argentina magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 54 Argentina magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa magnetoencephalography market by Country, 2018 - 2030 (USD Million)
Table 58 South Africa magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 59 South Africa magnetoencephalography market by Product, 2018 - 2030 (USD Million)
Table 60 South Africa magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia magnetoencephalography market by Product, 2018 - 2030 (USD Million)
Table 63 Saudi Arabia magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 64 UAE magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 65 UAE magnetoencephalography market by Product, 2018 - 2030 (USD Million)
Table 66 UAE magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 67 Kuwait magnetoencephalography market by Application, 2018 - 2030 (USD Million)
Table 68 Kuwait magnetoencephalography market by Product, 2018 - 2030 (USD Million)
Table 69 Kuwait magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
Table 70 Participant’s overview
Table 71 Financial performance
Table 72 Key companies undergoing expansions
Table 73 Key companies undergoing acquisitions
Table 74 Key companies undergoing collaborations
Table 75 Key companies launching new products/services
Table 76 Key companies undergoing partnerships
Table 77 Key companies undertaking other strategies
LIST OF FIGURES


Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Diagnostic Enzymes market: market outlook
Fig. 14 Diagnostic Enzymes competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Diagnostic Enzymes market driver impact
Fig. 18 Diagnostic Enzymes market restraint impact
Fig. 19 Diagnostic Enzymes market: Type movement analysis
Fig. 20 Diagnostic Enzymes market: Type outlook and key takeaways
Fig. 21 Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 UNG market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 RNase inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Bst polymerase (LAMP enzyme) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 PCR Master Mix market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Lyophilised Polymerase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Angiotensin converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Renin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Glucose oxidase/glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Urease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Horseradish peroxidase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Diagnostic Enzymes market: Application movement analysis
Fig. 50 Diagnostic Enzymes market: Application outlook and key takeaways
Fig. 51 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Diagnostic Enzymes market: Product movement analysis
Fig. 59 Diagnostic Enzymes market: Product outlook and key takeaways
Fig. 60 Molecular Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Clinical Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Diagnostic Enzymes market: End Use movement analysis
Fig. 63 Diagnostic Enzymes market: End Use outlook and key takeaways
Fig. 64 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Clinical Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Other End Users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Global Diagnostic Enzymes market: Regional movement analysis
Fig. 68 Global Diagnostic Enzymes market: Regional outlook and key takeaways
Fig. 69 Global Diagnostic Enzymes market share and leading players
Fig. 70 North America, by country
Fig. 71 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 U.S. key country dynamics
Fig. 73 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Canada key country dynamics
Fig. 75 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Mexico key country dynamics
Fig. 77 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 UK key country dynamics
Fig. 80 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Germany key country dynamics
Fig. 82 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 France key country dynamics
Fig. 84 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Italy key country dynamics
Fig. 86 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Spain key country dynamics
Fig. 88 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Denmark key country dynamics
Fig. 90 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Sweden key country dynamics
Fig. 92 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Norway key country dynamics
Fig. 94 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 China key country dynamics
Fig. 97 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Japan key country dynamics
Fig. 99 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 India key country dynamics
Fig. 101 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Thailand key country dynamics
Fig. 103 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 South Korea key country dynamics
Fig. 105 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Australia key country dynamics
Fig. 107 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Brazil key country dynamics
Fig. 110 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Argentina key country dynamics
Fig. 112 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 South Africa key country dynamics
Fig. 115 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 116 Saudi Arabia key country dynamics
Fig. 117 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 UAE key country dynamics
Fig. 119 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Kuwait key country dynamics
Fig. 121 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 122 Market share of key market players- Diagnostic Enzymes market


More Publications